Immunogen Collaborates with Takeda to Develop and Commercialise Elahere® in Japan
By Ashish Tripathi
Pharma Deals Review: Vol 2023 Issue 9 (Table of Contents)
Published: 15 Sep-2023
DOI: 10.3833/pdr.v2023.i9.2803 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In a bid to bolster its oncology pipeline, Takeda has entered into an exclusive license agreement with ImmunoGen...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS